Patent Expands Immunogenic Coverage of α-Lactalbumin-Based Vaccine PlatformTechnology Addresses Substantial Unmet Need in Preventive Oncology with Multi-Billion Dollar Market PotentialSAN JOSE, Calif., July 24, 2025 /PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today announced that the United States Patent and Trademark Office (USPTO) will issue U.S. Patent Number 12,370,244 on July 29, 2025, cove ...

收购交易核心条款 - 礼来公司以每股10.50美元现金加最高3美元或有价值权(CVR)的条件收购Verve Therapeutics全部流通股 [1] - 交易包含非交易型或有价值权(CVR)，该权利在达到特定里程碑时支付 [1] - 要约于2025年7月23日美国东部时间23:59到期未延期 [1] 交易执行情况 - 截至到期时间共49,882,464股(占流通股55.7%)被有效投标且未撤回 [2] - 礼来及其全资子公司Ridgeway Acquisition Corporation已接受所有有效投标股份并将及时支付 [2] - 交易预计于2025年7月25日完成 [3] 交易相关方 - 礼来法律顾问为Kirkland & Ellis LLP [3] - Verve财务顾问为Centerview Partners LLC和Guggenheim Securities LLC [3] - Verve法律顾问为Paul, Weiss, Rifkind, Wharton & Garrison LLP [3] Verve Therapeutics业务概况 - 临床阶段基因编辑公司，专注于心血管疾病治疗 [4] - 主要开发单疗程基因编辑药物替代现有慢性疗法 [4] - 三大核心项目分别靶向导致动脉粥样硬化的三种脂蛋白 [4] - VERVE-102靶向PCSK9基因，用于家族性高胆固醇血症和动脉粥样硬化心血管疾病 [4] - VERVE-201靶向ANGPTL3基因，用于难治性高胆固醇血症 [4] - VERVE-301靶向LPA基因，降低脂蛋白(a)水平 [4] 礼来公司业务概况 - 拥有近150年历史的跨国制药企业 [5] - 专注糖尿病、肥胖症、阿尔茨海默病、免疫系统疾病和癌症治疗领域 [5] - 通过生物技术、化学和基因医学推动新药研发 [5]

Telescope Innovations Selected to Join ALTA: the First US-Based Lithium Technology AcceleratorTelescope is among the first tech companies invited to the Arkansas Lithium Technology Accelerator (ALTA), engaging with industry leaders on the commercialization pathways for its lithium processing technologiesJuly 24, 2025 8:00 AM EDT | Source: Telescope Innovations Corp.Vancouver, British Columbia--(Newsfile Corp. - July 24, 2025) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) (FSE:4JU) ( ...

Matchpoint to receive up to $60 million in upfront payment and research funding, with up to $1 billion in total potential payments, including option exercise fee, development and commercial milestonesMatchpoint will lead all research activities through development candidate selection WATERTOWN, Mass., July 24, 2025 (GLOBE NEWSWIRE) -- Matchpoint Therapeutics, a biotechnology company pioneering the discovery of precision covalent medicines, today announced that it has entered into an exclusive option and lic ...

SHANGHAI and HONG KONG, July 24, 2025 (GLOBE NEWSWIRE) -- NETCLASS Technology INC (Nasdaq: NTCL; the “Company” or “NetClass”), a leading B2B smart education IT solutions provider with offices in Shanghai, Hong Kong, Singapore and Tokyo, today announced the establishment of a wholly owned subsidiary, NETCLASS INTERNATIONAL PTE. LTD., in Singapore, to support its international business development in AI applications, with a focus on expanding its footprint in Southeast Asia and other global markets. The new s ...

TARRYTOWN, N.Y., July 24, 2025 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced the winners of the 13th annual Regeneron Prize for Creative Innovation (the “Regeneron Prize”), which recognizes and rewards outstanding creativity and talent among early-career scientists in biomedical research. Each year, top U.S. research universities nominate their most promising graduate students and postdoctoral fellows for this honor. These nominees are invited to develop and pitch their ...

– Peer-reviewed publication in Annals of Clinical and Translational Neurology highlights the use of the MSA Atrophy Index developed to diagnose and track disease progression in Multiple System Atrophy – MELBOURNE, Australia and SAN FRANCISCO, July 24, 2025 (GLOBE NEWSWIRE) -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today announced that an innovative neuroimaging ...

TORONTO, July 24, 2025 (GLOBE NEWSWIRE) -- Xtract One Technologies (TSX: XTRA)(OTCQX: XTRAF)(FRA: 0PL) ("Xtract One" or the "Company") today announced its SmartGateway screening solution has been chosen by a leading, global performing arts company, known for permanent and touring live entertainment, to amplify security for its shows. The initial deployment will support a number of the organization's touring performances across dozens of venue locations beginning earlier in 2025. Further deployments are in p ...

Second Quarter 2025 Financial Highlights Second Quarter 2025 Business Highlights PLYMOUTH, Mich. and ROLLE, Switzerland, July 24, 2025 (GLOBE NEWSWIRE) -- Garrett Motion Inc. (Nasdaq: GTX) ("Garrett" or the "Company"), a leading differentiated automotive technology provider, today announced its financial results for the three months ended June 30, 2025. Additionally, the Company's Board of Directors has declared a cash dividend of $0.06 per share of common stock, payable on September 16, 2025, to shareholde ...

Trimble is a global technology company that connects the physical and digital worlds, transforming the ways work gets done. With relentless innovation in precise positioning, modeling and data analytics, Trimble enables essential industries including construction, geospatial and transportation. Whether it's helping customers build and maintain infrastructure, design and construct buildings, optimize global supply chains or map the world, Trimble is at the forefront, driving productivity and progress. For mo ...